• Dra. Marta Guerra Rebollo

Dr. Marta Guerra Rebollo
Grup d’ Enginyeria de Materials (Gemat)
IQS School of Engineering
Universitat Ramon Llull
Via Augusta 390, E-08017
Barcelona, Spain
Tel.:+34 932 672 000
Fax: +34 939 056 266

email: 
marta.guerra@iqs.url.edu

Llicenciada en Biologia (2005, Universitat Pompeu Fabra).

Diploma d’ Estudis Avançats (DEA) en Investigació Biomèdica (2007, Universitat de Barcelona).

Doctorat en Biomedicina (2011, Universitat de Barcelona).

Investigadora Post doctoral en el grup de Teràpia Cel·lular de l’Institut de Química Avançada de Cataluña (2011-2018, IQAC-CSIC).

Investigadora Post doctoral en el grup d’Enginyeria de Materials (2018- , Institut Químic de Sarrià).

 

ASSIGNATURES

Professora del laboratori de Bioquímica (Grau en Biotecnologia).

 

PUBLICACIONS RELLEVANTS

  • Fornaguera C, Guerra-Rebollo M, Lázaro MÁ, Cascante A, Rubio N, Blanco J, Borrós S. In Vivo Retargeting of Poly(beta aminoester) (OM-PBAE) Nanoparticles is Influenced by Protein Corona.Adv Healthc Mater. 2019 Sep 2:e1900849. doi: 10.1002/adhm.201900849. [Epub ahead of print]

    Guerra-Rebollo M, Garrido C, Sánchez-Cid L, Soler-Botija C, Meca-Cortés O, Rubio N, Blanco J. Targeting of replicating CD133 and OCT4/SOX2 expressing glioma stem cells selects a cell population that reinitiates tumors upon release of therapeutic pressure.Sci Rep. 2019 Jul 2;9(1):9549. doi: 10.1038/s41598-019-46014-0

    Laura Balcells; Cristina Fornaguera; Pau Brugada-Vilà; Marta Guerra-Rebollo; Óscar Meca-Cortés; Gema Martínez; Núria Rubio; Jerónimo Blanco; Jesús Santamaría; Anna Cascante; Salvador Borrós. SPIONs’ Enhancer Effect on Cell Transfection: An Unexpected Advantage for an Improved Gene Delivery System. ACS Omega. 4 - 2, pp. 2728 - 2740. 2019.

    Cristina Fornaguera ; Miguel Ángel Lázaro; Pau Brugada-Vilà; Irene Porcar; Ingrid Morera; Marta Guerra-Rebollo; Cristina Garrido; Nuria Rubio; Jerónimo Blanco; Anna Cascante; Salvador Borrós. Application of an assay Cascade methodology for a deep preclinical characterization of polymeric nanoparticles as a treatment for gliomas. Drug Delivery. Volume 25 - Issue 1, pp. 472 - 483. (Spain): 2018.

    Marta Guerra-Rebollo; Carolina Nogueira de Morales; Cristina Alcoholado; Carolina Soler-Botija; Lourdes Sánchez-Cid; Olaia F.Vila; Oscar Meca-Cortés; Sara Ramos-Romero; Núria Rubio; José Becerra; Jerónimo Blanco; Cristina Garrido. Glioblastoma Bystander Cell Therapy: Improvements in Treatment and Insights into the Therapy Mechanisms. Mol Ther Oncolytics. Sep 15 - 11, pp. 39 - 51. 2018.

    Cristina Fornaguera; Marta Guerra-Rebollo; Miguel Ángel Lázaro; Cristina Castells-Sala; Oscar Meca-Cortés; Victor Ramos-Pérez; Anna Cascante; Núria Rubio; Jerónimo Blanco; Salvador Borrós. Mrna Delivery System for Targeting Antigen-Presenting Cells In Vivo. Advanced Healthcare Materials. Sep;7(17), (Spain): 2018.

    Oscar Meca-Cortés; Marta Guerra-Rebollo; Cristina Garrido; Salvador Borrós; Nuria Rubio; Jerónimo Blanco. CRISPR/Cas9-Mediated Knockin Application in Cell Therapy: A Non-viral Procedure for Bystander Treatment of Glioma in Mice. Molecular Therapy Nucleic Acids. 8, pp. 395 - 403. 2017.

    Lourdes Sanchez-Cid; Monica Pons; Juan Jose Lozano; Nuria Rubio; Marta Guerra-Rebollo; Aroa Soriano; Laia Paris-Coderch; Miquel F Segura; Raquel Fueyo; Judit Arguimbau; Erika Zodda; Raquel Bermudo; Immaculada Alonso; Xavier Caparrós; Marta Cascante; Arash Rafii; Yibin Kang; Marian Martínez-Balbás; Stephen J. Weiss; Jerónimo Blanco; Montserrat Muñoz; Pedro L. Fernández; Timothy M. Thomson. MicroRNA-200, associated with metastatic breast cancer, promotes traits of mammary luminal progenitor cells.Oncotarget. 8 - 48, pp. 83384 - 83406. 2017.

    Duchi S.; Ramos-Romero S; Dozza B; Guerra-Rebollo M; Cattini L; Ballestri M; Dambruoso P; Guerrini A; Sotgiu G; Varchi G; Lucarelli E; Blanco J. Development of near-infrared photoactivable phthalocyanine-loaded nanoparticles to kill tumor cells: An improved tool for photodynamic therapy of solid cancers.Nanomedicine. Oct - 12(7), pp. 1885 - 1897. 2016.

    Ma SP; Vila OF; Garrido C; Cano I; Guerra-Rebollo M; Navarro M; Meca-Cortés O; Engel E; Rubio N; Blanco J. Real-Time Bioluminescence Imaging of Cell Distribution, Growth, and Differentiation in a Three-Dimensional Scaffold Under Interstitial Perfusion for Tissue Engineering.Tissue Eng Part C Methods. Sep - 22(9), pp. 864 - 872. 2016.

    Guerra-Rebollo M, Mateo F, Franke K, Huen MS, Lopitz-Otsoa F, Rodríguez MS, Plans V, Thomson TM. Nucleolar exit of RNF8 and BRCA1 in response to DNA damage. .pp. 2365 - 2376. 2012.Exp Cell Res.1;318(18).

    Celià-Terrassa T, Meca-Cortés O, Mateo F, de Paz AM, Rubio N, Arnal-Estapé A, Ell BJ, Bermudo R, Díaz A, Guerra-Rebollo M, Lozano JJ, Estarás C, Ulloa C, Álvarez-Simón D, Milà J, Vilella R, Paciucci R, Martínez-Balbás M, de Herreros AG, Gomis RR, Kang Y, Blanco J, Fernández PL, Thomson TM. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. J Clin Invest. 2012. 122(5). pp. 1849 -1868

    Scheper J, Guerra-Rebollo M, Sanclimens G, Moure A, Masip I, González-Ruiz D, Rubio N, Crosas B, Meca-Cortés O, Loukili N, Plans V, Morreale A, Blanco J, Ortiz AR, Messeguer A, Thomson TM. Protein-protein interaction antagonists as novel inhibitors of non-canonical polyubiquitylation. PLoS One.2010. 5(6):e11403.

    Thomson TM, Guerra-Rebollo M. Ubiquitin and SUMO signalling in DNA repair. Biochem Soc Trans. 2010. 38(Pt 1).pp.116 – 131

    Plans V, Guerra-Rebollo M, Thomson TM. Regulation of mitotic exit by the RNF8 ubiquitin ligase. Oncogene. 2008.27(10). pp.1355-1365